Literature DB >> 18487548

Nephrogenic systemic fibrosis in Japan: advisability of keeping the administered dose as low as possible.

Yoshito Tsushima, Ayako Takahashi-Taketomi, Keigo Endo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18487548     DOI： 10.1148/radiol.2473072101

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  3 in total

Review 1.  Pathophysiology of gadolinium-associated systemic fibrosis.

Authors:  Brent Wagner; Viktor Drel; Yves Gorin
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-04

2.  Safety of gadoterate meglumine (Gd-DOTA) as a contrast agent for magnetic resonance imaging: results of a post-marketing surveillance study in Japan.

Authors:  Tsuneo Ishiguchi; Shoki Takahashi
Journal:  Drugs R D       Date:  2010

3.  Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases.

Authors:  Zhitong Zou; Lin Ma
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.